Noah Labs receives significant funding from the European Regional Development Fund (ERDF) and the state of Brandenburg for the ‘Noah Labs Pre-Sense’ project. This funding supports the development of an innovative application for the early detection of cardiac decompensation by analysing multiparametric vital data, with the aim of improving diagnostics and healthcare and driving innovation in the field of digital healthcare solutions.
Berlin, 05.09.2024 - Noah Labs is pleased to announce that the company has received significant funding from the European Regional Development Fund (ERDF) and the State of Brandenburg. These funds will be provided to support the project ‘Noah Labs Pre-Sense: Multiparametric application for early detection of cardiac decompensation’.
The ‘Noah Labs Pre-Sense’ project aims to develop a state-of-the-art application that enables the early detection of cardiac decompensation by recording and analysing various vital parameters. This solution is intended to help medical professionals diagnose life-threatening conditions at an early stage and take preventive measures quickly in order to avoid serious heart disease and reduce the burden on the healthcare system.
The main objective of the project is to create a user-friendly platform that uses multi-parametric data analysis to improve diagnostics and optimise healthcare. Other objectives include promoting early medical interventions and supporting professionals in decision-making. In addition, the project contributes to strengthening Noah Labs' innovative strength in the field of digital health solutions.
‘This funding from the EU and the state of Brandenburg is a significant step for our company,’ says Oliver Piepenstock, CEO. ‘Thanks to this support, we can develop a groundbreaking solution that will not only revolutionise healthcare, but also significantly improve the early detection of heart disease.’
For more information, please visit our website or contact us at info@noah-labs.com
.png)
